Bioceres Crop Solutions Corp. (BIOX) Income Statement
BIOX FY2026 at a glance
Fiscal year ended June 30, 2026 · U.S. dollarsBIOX revenue and net income
Where BIOX's revenue goes
FY2026Each bar shows an amount and its share of revenue. BIOX kept −96.8% of revenue as net income.
BIOX profit margins
BIOX growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −28.7% | −17.2% | +2.8% | +46.8% |
| Gross profit | −35.7% | −23.0% | −1.9% | +52.4% |
| Operating income | — | −87.7% | −69.6% | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BIOX quarterly EPS vs estimates
Bioceres Crop Solutions beat the analyst EPS estimate in 1 of the last 8 quarters. Next report: November 11, 2026.
BIOX income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $237.8M | $333.3M | $464.8M | $419.4M | $328.5M | $206.7M | $172.4M | $160.3M | $133.5M | $93.7M |
| Cost of revenue | $155.4M | $205.2M | $283.2M | $239.2M | $202.0M | $115.8M | $92.9M | $86.7M | $77.1M | $59.9M |
| Gross profit | $82.4M | $128.2M | $181.6M | $180.2M | $126.4M | $90.9M | $79.5M | $73.6M | $56.4M | $33.8M |
| Research & development | — | $14.9M | $17.2M | $15.3M | $6.9M | $5.6M | $4.2M | $3.7M | $4.0M | $4.0M |
| Sales, general & admin | — | $88.3M | $94.3M | $85.5M | $57.4M | $44.4M | $29.5M | $30.8M | $35.3M | $27.4M |
| Total operating expenses | $82.3M | $128.9M | $136.8M | $111.8M | $84.9M | $50.0M | $41.3M | $41.8M | $38.5M | $41.3M |
| Operating income | $100,000 | −$761,904 | $44.8M | $54.2M | $39.9M | $38.4M | $39.1M | $32.1M | $15.7M | −$706,924 |
| Interest income | — | — | — | — | — | — | — | $1.5M | $41.0M | $10.2M |
| Interest expense | $50.9M | $25.6M | $26.9M | $23.8M | $17.9M | $21.2M | $19.4M | $21.8M | $15.6M | $14.9M |
| Income before taxes | −$51.0M | −$57.6M | $10.0M | $19.1M | $14.1M | $10.5M | $6.4M | −$9.4M | −$25.2M | −$22.4M |
| Income taxes | $3.4M | $1.3M | $3.8M | −$1.1M | $18.0M | $14.4M | $2.2M | $7.0M | −$10.9M | −$5.6M |
| Net income | −$230.3M | −$55.4M | $3.2M | $18.8M | −$7.2M | −$6.9M | $3.4M | −$18.4M | −$11.0M | −$11.8M |
| EBITDA | $100,000 | −$9.8M | $55.5M | $72.4M | $47.9M | $43.7M | $30.6M | $17.3M | −$12,765 | $3.9M |
| EPS (diluted) | −$0.84 | −$0.80 | $0.06 | $0.26 | −$0.14 | −$0.16 | $0.24 | −$0.93 | −$0.17 | −$0.82 |
| Gross margin | 34.7% | 38.4% | 39.1% | 43.0% | 38.5% | 44.0% | 46.1% | 45.9% | 42.2% | 36.1% |
| Operating margin | 0.0% | −0.2% | 9.6% | 12.9% | 12.1% | 18.6% | 22.7% | 20.0% | 11.8% | −0.8% |
| Net margin | −96.8% | −16.6% | 0.7% | 4.5% | −2.2% | −3.3% | 1.9% | −11.5% | −8.3% | −12.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57.0M | $38.2M | $73.7M | $77.4M | $74.4M | $59.6M | $98.9M | $92.6M | $124.3M | $84.0M | $140.3M | $116.2M |
| Cost of revenue | $43.2M | $26.7M | $47.4M | $41.8M | $50.2M | $36.1M | $57.6M | $55.4M | $78.2M | $41.4M | $88.8M | $72.7M |
| Gross profit | $13.8M | $11.5M | $26.3M | $35.6M | $24.2M | $23.5M | $41.3M | $37.2M | $46.1M | $42.6M | $51.5M | $43.5M |
| Research & development | — | — | $2.3M | $5.7M | $2.7M | $3.7M | $2.0M | $4.4M | $5.4M | $3.6M | $3.6M | $4.6M |
| Sales, general & admin | — | — | $12.6M | $16.5M | $22.7M | $16.9M | $17.5M | $21.1M | $14.1M | $29.6M | $31.2M | $26.8M |
| Total operating expenses | $23.9M | $18.0M | $18.5M | $27.9M | $39.1M | $22.5M | $26.1M | $33.6M | $36.6M | $29.3M | $34.7M | $39.4M |
| Operating income | −$10.1M | −$6.5M | $7.8M | $7.8M | −$14.9M | $933,210 | $15.2M | $3.7M | $9.5M | $13.2M | $16.8M | $5.3M |
| Interest expense | $20.3M | $6.6M | $7.0M | $8.5M | $26.2M | $6.1M | $5.3M | $6.1M | $15.6M | $4.4M | $7.3M | $7.0M |
| Income before taxes | −$30.0M | −$17.5M | −$1.4M | −$5.4M | −$41.2M | −$5.6M | $7.3M | −$7.5M | −$6.1M | $8.8M | $9.5M | −$2.2M |
| Income taxes | $1.8M | −$4.0M | $3.1M | $2.1M | $6.8M | −$4.0M | $636,153 | −$1.3M | $4.0M | −$955,832 | $8.3M | $429,040 |
| Net income | −$27.5M | −$12.3M | −$183.0M | −$7.3M | −$44.3M | −$1.3M | $143,535 | −$6.4M | −$1.5M | $9.3M | $108,449 | −$4.6M |
| EBITDA | −$10.1M | −$3.1M | $6.8M | $9.0M | −$10.8M | $11.3M | $13.8M | $3.9M | $15.4M | $20.1M | $19.7M | $9.6M |
| EPS (diluted) | −$0.50 | −$0.14 | −$0.08 | −$0.12 | −$0.70 | −$0.02 | $0.01 | −$0.09 | −$0.03 | $0.14 | $0.02 | −$0.07 |
| Gross margin | 24.2% | 30.1% | 35.7% | 46.0% | 32.5% | 39.4% | 41.8% | 40.2% | 37.1% | 50.7% | 36.7% | 37.5% |
| Operating margin | −17.7% | −17.0% | 10.6% | 10.0% | −20.0% | 1.6% | 15.4% | 4.0% | 7.6% | 15.7% | 12.0% | 4.6% |
| Net margin | −48.2% | −32.2% | −248.4% | −9.5% | −59.5% | −2.2% | 0.1% | −6.9% | −1.2% | 11.0% | 0.1% | −4.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BIOX's financial statements (latest annual report filed June 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BIOX financial results
In fiscal year 2026 (ended June 30, 2026), Bioceres Crop Solutions reported revenue of $237.8 million, down 28.7% from the year before. It had a net loss of $230.3 million, a net profit margin of −96.8%. Diluted earnings per share came to −$0.84. Over five years revenue grew at an average rate of 2.8% a year.
See the BIOX stock overview for the latest quote and news, or the BIOX chart for price history and technical indicators.
BIOX income statement FAQ
What is Bioceres Crop Solutions's annual revenue?
Bioceres Crop Solutions reported total revenue of $237.8 million for fiscal year 2026, which ended on June 30, 2026. That was down 28.7% from $333.3 million the previous year.
Is Bioceres Crop Solutions profitable?
No. Bioceres Crop Solutions reported a net loss of $230.3 million in fiscal 2026, a net profit margin of −96.8%; its operating margin was 0.0%.
What is Bioceres Crop Solutions's gross margin?
Bioceres Crop Solutions's gross margin was 34.7% in fiscal 2026: for every $100 of revenue, Bioceres Crop Solutions kept $35 after the direct cost of its products and services.
How fast is Bioceres Crop Solutions growing?
Revenue grew 2.8% a year on average over the last five fiscal years, from $206.7 million to $237.8 million.
What are Bioceres Crop Solutions's earnings per share?
Bioceres Crop Solutions earned $-0.84 per diluted share in fiscal 2026, compared with $-0.80 a year earlier.
When will Bioceres Crop Solutions report its next earnings?
Bioceres Crop Solutions is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.
When does Bioceres Crop Solutions's fiscal year end?
Bioceres Crop Solutions's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on June 30, 2026.